| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.3 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |